Your Current Location: Brand Column >医生手记
Don’t Panic Over Infections During Pregnancy! A Safe Medication & Pitfall Avoidance Checklist for Pregnant & Postpartum Women
2026-07-14
Author:lin jing
Tags:
妊娠期并发症
  
Page Views:78

Pregnant women have unique physiological conditions. Once an infection occurs, pathogens may cross the placenta via the genital tract or blood circulation and trigger intrauterine fetal infection. Therefore, the selection of antibacterial medications is of critical importance. Rational medication can effectively control maternal infection while minimizing adverse drug reactions to the fetus. Which antibacterial agents are relatively safe for use in pregnancy? What are the major adverse effects of antibiotics on fetuses? How to select appropriate antibacterial drugs based on infection types?


I. Selection of Antibacterial Drugs in Pregnancy

The FDA once classified the risk of medications for pregnant women into five categories: A, B, C, D and X. Category A drugs have been proven free of medication risks in clinical studies involving pregnant women and can be safely administered throughout gestation. For Category B drugs, animal experiments have yielded no evidence of hazards to humans, yet human clinical trial data remain insufficient, allowing selective clinical application[1]. Although this classification system has been phased out by the FDA and replaced by the Pregnancy and Lactation Labeling Rule (PLLR) in 2015, it retains profound clinical reference value and still serves as a preliminary assessment standard for medication use during pregnancy. Antibacterial drugs cover a wide range of varieties, with stark disparities in their corresponding pregnancy risk ratings.


The risk stratification of antibacterial agents under the A-X classification system is presented as follows[2-3]:

新建 PPTX 演示文稿_01.png

A 2025 review on the safe use of antibiotics in pregnancy supplemented safety data for several antibacterial drugs[4]:

新建 PPTX 演示文稿_02.png

It can be concluded that drugs falling under Category A and B deliver superior safety for gestational use per the two classification criteria, including penicillins and cephalosporins.


II. Choosing Safe Antibacterial Agents by Infection Type

In clinical practice, the selection of antibiotics is comprehensively determined by the predominant pathogenic bacteria at the infection site and drug susceptibility test results. The core principle for antibiotic administration during pregnancy is to effectively manage maternal infection while mitigating potential fetal risks to the greatest extent. Below are several common infectious diseases encountered in gestation:


1、Gynecologic Genital Tract Infections[2,3,5,6]

新建 PPTX 演示文稿_03.png


2、Urinary Tract Infections[3,7]

新建 PPTX 演示文稿_04.png


3、 Respiratory Tract Infections[3]

新建 PPTX 演示文稿_05.png

Medication use in pregnancy is never a trivial matter, as antibiotic selection directly bears on maternal and fetal safety. Clinically, low-risk drugs such as penicillins and cephalosporins are prioritized. Antibiotics carrying teratogenic or organ-damaging risks should be avoided whenever possible. For antifungal agents like clotrimazole and miconazole, as well as anaerobicides such as metronidazole, vaginal topical formulations are preferred during pregnancy. Oral metronidazole may be cautiously prescribed in the second and third trimesters based on actual disease conditions.


Reminders for All Expectant Mothers

Never purchase and take medicines on your own when infected during pregnancy. Always seek guidance from professional physicians to receive individualized medication regimens tailored to infection type, gestational age and personal physical status. This approach controls maternal inflammation while safeguarding fetal safety to the maximum.


References

[1] Dong Yue, Zhao Ruilin. Handbook of Modern Obstetrics and Gynecology Diagnosis and Treatment[M]. Beijing Medical University Press, 2001.
[2] Liu Zhaohui. Guidelines for Antibiotic Use in Obstetrics and Gynecology[J]. Chinese Journal of Obstetrics and Gynecology, 2011, 46(3):4.
[3] Expert Committee on Rational Drug Use, National Health and Family Planning Commission. National Guidelines for Antimicrobial Therapy (3rd Edition)[M]. Beijing: People’s Medical Publishing House, 2023.
[4] Nguyen J, Madonia V, Bland C M, et al. A review of antibiotic safety in pregnancy—2025 update[J]. Pharmacotherapy, 2025, 45(4).
[5] Cooperative Group of Infectious Diseases, Obstetrics and Gynecology Branch of Chinese Medical Association. Revised Clinical Practice Guidelines for Pelvic Inflammatory Disease (2019 Edition)[J]. Chinese Journal of Obstetrics and Gynecology, 2019, 54(7):433-437.
[6] Cooperative Group of Infectious Diseases, Obstetrics and Gynecology Branch of Chinese Medical Association. Chinese Guidelines for the Diagnosis and Treatment of Vulvovaginal Candidiasis (2024 Edition)[J]. Chinese Journal of Obstetrics and Gynecology, 2024, 59(07):499-504.
[7] Special Committee of Nephrology and Blood Purification, Chinese Women Physicians Association. Expert Consensus on the Diagnosis and Treatment of Urinary Tract Infections in Chinese Women[J]. National Medical Journal of China, 2017, 97(36).

[8] Chinese Medical Association, Clinical Pharmacy Branch of Chinese Medical Association, Chinese Medical Journal Press, et al. Grassroots Guidelines for Rational Medication in Acute Upper Respiratory Tract Infections[J]. Chinese Journal of General Practitioners, 2020, 19(08):689-697.


Author Profile

林靖网站.jpg

Editor-in-Charge: Qing Huan
Reviewer: Ma Ye


评论(0)
精彩评论